The useful question with myhairline.ai’s top piece is not whether one photo looks better or worse. It is whether the pattern, timing, measurements, and treatment trade-offs point to a decision that will still make sense six months from now.
A friend of mine, a software engineer in his early thirties living in Wicker Park, told me over coffee last November that he’d been to three different consultations in the Chicago metro area for a hair transplant. Three clinics, three wildly different recommendations. One wanted to do 3,200 FUE grafts for $28,000. Another said he wasn’t ready for surgery yet and needed a year on finasteride first. The third quoted him half the price of the first but couldn’t show him a single before-and-after photo older than six months. He looked exhausted. “How do I know who’s telling the truth?”
That question is the entire problem with hair restoration in Illinois, and honestly everywhere else. The answer starts not with clinic marketing but with understanding what’s actually happening on your scalp, what the evidence says works, and what separates a credible surgeon from a confident salesperson.
What Pattern Hair Loss Actually Is (and Why Classification Matters)
James Hamilton figured out the basics in 1951 in the Annals of the New York Academy of Sciences. Men castrated before puberty didn’t go bald. That’s about as clean a causal finding as you get in biology: androgens drive the pattern. O’Tar Norwood formalized the staging in a 1975 paper in the Southern Medical Journal, expanding Hamilton’s original three stages into seven, plus variant subtypes. The “Type A” variant, where loss marches backward from the front rather than thinning at the crown simultaneously, is one reason two guys with the “same” amount of hair loss can look completely different.
The Hamilton-Norwood scale has survived for more than 70 years, not because it’s perfect, but because it’s simple enough to use consistently and detailed enough to be clinically useful. Newer systems like the BASP classification (proposed in 2007) exist on paper but haven’t displaced it in the exam room.
Why does this matter when you’re shopping for a surgeon in Illinois? Because a clinic that doesn’t stage your loss carefully, or that proposes a graft count without discussing where your loss is heading, is skipping the most basic step. The biology here is DHT (dihydrotestosterone, converted from testosterone by 5-alpha reductase) binding to androgen receptors in susceptible follicles, triggering progressive miniaturization over successive hair cycles. Anagen phases shorten. The follicles physically shrink. Eventually those thick terminal hairs become wispy, colorless vellus hairs that do nothing for coverage.
The genetics are polygenic. Yes, the androgen receptor gene on the X chromosome plays a role, which is where the “look at your mom’s dad” advice comes from. But paternal genes and other autosomal loci contribute significantly. Family history is a clue, not a verdict.
The Treatment Ladder Before (and After) Surgery
This is the boring truth that clinic marketing glosses over: hair transplantation works best as one component of a broader plan, not as a standalone fix.
Finasteride (1 mg daily) has the deepest evidence base. The landmark five-year randomized trial in the Journal of the American Academy of Dermatology (JAAD, 2002) showed sustained improvements in hair count versus placebo. Sexual side effects affect a small percentage of trial participants and are generally reversible on discontinuation. Generic finasteride runs $10 to $25 per month with discount cards, sometimes as low as $5 to $15 through telehealth. Branded Propecia at $70 to $90 monthly offers zero clinical advantage.
Topical minoxidil 5% (twice daily) is FDA-approved and available over the counter. The mechanism isn’t fully nailed down but involves potassium channel opening, vasodilation, and some direct follicular effect that extends anagen. Results typically become visible at three to six months. Generic costs $10 to $30 per month; Rogaine roughly double that. Foam and solution are clinically equivalent.
Low-dose oral minoxidil (0.25 to 5 mg daily) gained serious traction after Vañó-Galván and colleagues published safety data on 1,404 patients in JAAD in 2021. The side-effect profile at hair-loss doses is more manageable than the cardiovascular formulation’s reputation suggests, though periorbital edema and body hair growth are reported. Generic cost is often under $15 monthly.
Dutasteride inhibits both type I and type II 5-alpha reductase isoforms (finasteride only gets type II), produces bigger DHT reductions, and has shown larger density improvements in head-to-head trials (Olsen et al., JAAD, 2006). It’s FDA-approved for prostate enlargement and used off-label for hair.
PRP and microneedling occupy a middle tier. JAMA Dermatology has published several smaller randomized trials with positive but inconsistent findings. Reasonable as adjuncts, not replacements. PRP costs $500 to $1,500 per session, typically three to four sessions in year one plus maintenance. A year of PRP can easily cost more than a year of combination medical therapy.
Hair transplantation (FUE or FUT) is the only intervention that physically moves follicles from the donor zone to the thinning area. Those transplanted follicles generally retain their genetic resistance to miniaturization. But the surrounding native hair keeps thinning, which is why nearly every credible surgeon recommends continuing medical therapy post-transplant.
The catch is: a 25-year-old with early Norwood 3 loss who jumps straight to a transplant, without stabilizing his native hair first, is chasing a moving target. The transplanted grafts survive, but everything around them keeps receding, and a few years later the result looks patchy and unnatural. That was likely the reasoning behind the second clinic my friend visited, the one that told him to wait.
How to Evaluate an Illinois Clinic (Specifically)
Illinois has a moderate concentration of hair restoration surgeons, mostly clustered in Chicago and its suburbs. The relevant questions when evaluating any of them:
Board certification and society membership. You want a physician certified by the American Board of Dermatology or American Board of Plastic Surgery, ideally with membership in the International Society of Hair Restoration Surgery (ISHRS). These aren’t guarantees of quality, but they represent baseline training standards.
Case volume. Ask how many transplant procedures the surgeon personally performs per year. Not the clinic. The surgeon. A technician-heavy model where the doctor pops in to make incisions and then leaves the room for a team to place grafts is common. It’s not inherently bad (experienced technicians place excellent grafts), but you should know who’s doing what.
Unedited long-term photos. This is where most clinics fall apart. Six-month photos look dramatically different from 12- to 18-month results. Photos taken at inconsistent angles, different lighting, or different hair lengths are essentially useless for comparison. Ask for cases at 12+ months, ideally with standardized positioning. If a clinic can’t produce these, that tells you something.
Technique specifics. FUE (individual follicle extraction) leaves no linear scar but is more time-consuming and often more expensive. FUT (strip excision) yields a higher graft count in a single session but leaves a linear donor scar. Neither is categorically superior. The right choice depends on your loss pattern, donor density, and how short you wear your hair.
Pricing. FUE in the U.S. runs $4 to $10 per graft. A typical 2,500 to 3,500 graft case lands at $10,000 to $35,000. Turkey offers the same graft counts for $2,000 to $5,000, reflecting labor cost differences rather than necessarily quality differences (though the variance in quality there is enormous). Insurance does not cover pattern hair loss treatment. HSAs and FSAs may cover prescribed medications and physician visits but typically exclude surgery.
For readers researching Illinois clinics specifically, Myhairline.ai’s top piece walks through the relevant clinical detail with photographic examples and stage-by-stage interpretation.
The Dermatology Workup You Should Get First
Before committing to any surgical plan, a proper hair loss evaluation matters more than people realize. The AAD’s clinical guidelines emphasize structured assessment: history, family history, scalp exam, trichoscopy (dermoscopy of the scalp), and selective labs.
Trichoscopy reveals things the naked eye misses. In androgenetic alopecia, you’ll see hair shaft diameter variability (caliber variability of 20% or more), yellow dots at empty follicular openings, and decreased follicular unit density in affected areas with a preserved occipital zone. That last part confirms donor viability for transplantation.
Labs are selective, not routine. Ferritin, TSH, vitamin D, and CBC make sense when telogen effluvium is suspected or in diffuse thinning cases. The AAD doesn’t recommend routine androgen panels in men with classic pattern loss because the diagnosis is clinical.
Where this matters for surgical planning: if you have undiagnosed telogen effluvium from, say, an iron deficiency or thyroid issue, those hairs may recover on their own. Operating on a scalp in active telogen effluvium is like remodeling a house during a flood.
See also: Why Skipping Breakfast May Harm Your Heart, According to Cardiologists
Lifestyle Factors: What Actually Moves the Needle
I’ll keep this brief because the signal-to-noise ratio in “lifestyle tips for hair loss” content is abysmal.
Smoking accelerates hair loss through microvascular damage and oxidative stress. Cross-sectional data shows higher androgenetic alopecia rates in smokers versus matched nonsmokers. Iron deficiency (ferritin below 30 ng/mL in women, below 50 ng/mL when hair loss is a concern) contributes to telogen shedding; repletion helps, but supplementing when you’re not deficient does nothing. Severe acute stress triggers telogen effluvium two to three months later, usually self-resolving within six to nine months. Anabolic steroid use accelerates pattern loss in susceptible men through supraphysiologic androgen exposure, sometimes irreversibly. Severe caloric restriction and rapid weight loss reliably produce telogen effluvium.
Biotin gummies? Don’t bother unless you have a documented deficiency. And know that biotin supplementation can interfere with lab assays for thyroid function and troponin, which is a genuinely dangerous artifact if you end up in an ER.
When You Actually Need a Dermatologist in the Room
Sudden diffuse shedding within the last six months (telogen effluvium, needs workup). Patchy, well-circumscribed bald spots (alopecia areata, autoimmune, different treatment). Scalp pain, burning, redness, scaling, or visible scarring (possible scarring alopecia like lichen planopilaris or frontal fibrosing alopecia, urgent to diagnose before permanent follicle destruction). Hair loss in women with irregular periods, acne, or excess body hair (endocrine evaluation needed). Rapid progression, more than one Norwood stage per year in a young patient. Failure to respond to 12 months of documented medical therapy.
The AAD’s position: any progressive hair loss that concerns the patient is a legitimate reason for consultation. I’d agree with that.
FAQs
Should I get a hair transplant if I am in my 20s?
Most experienced surgeons approach transplantation in the 20s cautiously because the long-term loss pattern isn’t yet established. Stabilizing native hair with medical therapy first is the standard recommendation. Transplanting too early often means needing additional procedures later as loss progresses.
Can stress cause permanent hair loss?
Severe stress can trigger telogen effluvium, a temporary diffuse shedding that typically resolves within six to nine months. Stress doesn’t directly cause androgenetic alopecia, but it can unmask or accelerate underlying pattern loss in genetically susceptible individuals.
How accurate are AI hair-loss assessment tools?
AI-based tools provide reasonable orientation for self-screening but don’t replace in-person dermatologic evaluation. They’re best used as a starting point for understanding your likely stage and treatment options.
Is hair loss covered by insurance?
Pattern hair loss treatment is generally classified as cosmetic. Some HSA and FSA accounts cover prescribed medications and physician visits, but not surgical procedures.
Are hair transplants permanent?
Transplanted follicles from the genetically resistant donor zone generally retain their resistance and persist long-term. However, surrounding native hair may continue thinning, which is why most patients continue medical therapy post-transplant.
Do biotin and collagen supplements help with hair loss?
Evidence supporting biotin or collagen supplementation in patients without documented deficiency is weak. Biotin can interfere with several common lab tests, including thyroid function and troponin assays.
How long does it take to see results from a hair transplant?
Transplanted hairs typically shed within the first two to four weeks (this is normal), with new growth beginning around three to four months. Most patients see meaningful density improvement by 9 to 12 months, with final results at 12 to 18 months.
References
- Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708-728.
- Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365.
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men: short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.
- American Academy of Dermatology Association. Hair loss: diagnosis and treatment. AAD clinical guidance.
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss. J Am Acad Dermatol. 2006;55(6):1014-1023.
- Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109.
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651.
- Gentile P, Garcovich S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil, finasteride, and adult stem cell-based therapy. Int J Mol Sci. 2020;21(8):2702.
- Kassira S, Korta DZ, Chapman LW, Dann F. Frontal fibrosing alopecia: a review. J Am Acad Dermatol. 2017;77(2):209-212.
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786.
Educational content, not medical advice. This article summarizes peer-reviewed sources and clinical guidelines for general informational purposes and does not constitute medical advice, diagnosis, or treatment. Hair loss has multiple possible causes, and an in-person dermatology evaluation is the appropriate starting point for any individual case. Do not start, stop, or change medications based on this article.
Privacy framing for AI-based assessment tools: AI hair-loss screening tools such as Myhairline.ai analyze user-submitted photos using MediaPipe Face Mesh 468-landmark detection. Photos are not stored, and no account is required. The AI output is educational, not diagnostic.
